Felice N van Erning
Overview
Explore the profile of Felice N van Erning including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
503
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Darai A, Koeter T, van Erning F, van Alphen R, Verheul H, Verheij M, et al.
Colorectal Dis
. 2025 Mar;
27(3):e70054.
PMID: 40059308
Aim: Treatment of rectal cancer has improved significantly over the past decades. However, the role of adjuvant chemotherapy remains a matter of debate. The aim of this study is to...
2.
Galanos L, Rijken A, Elferink M, Kok N, van Erning F, de Hingh I
Int J Cancer
. 2025 Feb;
PMID: 39963009
This study aims to assess the influence of colorectal cancer screening on the incidence of synchronous colorectal peritoneal metastases (CPM). Patients diagnosed with CPM between 2009 and 2022 were selected...
3.
Linssen J, Schafrat P, de Back T, van Erning F, van Leerdam M, Dekker E, et al.
Int J Cancer
. 2025 Feb;
PMID: 39907526
Small intestinal adenocarcinomas (SIAs) are associated with predisposing conditions, including inflammatory bowel disease (IBD) and celiac disease, but also genetic syndromes such as Lynch syndrome (LS) and familial adenomatous polyposis...
4.
van Erning F, van den Heuvel T, Sijtsma F, Boerma D, Brandt-Kerkhof A, Bremers A, et al.
Eur J Surg Oncol
. 2024 Sep;
50(12):108568.
PMID: 39241538
Introduction: To improve care for patients with colorectal peritoneal metastases (CRC-PM) or pseudomyxoma peritonei (PMP), the Dutch CRS-HIPEC quality registry was initiated in 2019. The aims are to describe the...
5.
Swartjes H, Sijtsma F, Elferink M, van Erning F, Moons L, Verheul H, et al.
Eur J Cancer
. 2024 Jun;
207:114155.
PMID: 38866635
No abstract available.
6.
Shen L, van Gestel A, Prinsen P, Vink G, van Erning F, Geleijnse G, et al.
JCO Clin Cancer Inform
. 2024 May;
8:e2300186.
PMID: 38753347
Purpose: Real-world evidence (RWE)-derived from analysis of real-world data (RWD)-has the potential to guide personalized treatment decisions. However, because of potential confounding, generating valid RWE is challenging. This study demonstrates...
7.
Swartjes H, Sijtsma F, Elferink M, van Erning F, Moons L, Verheul H, et al.
Eur J Cancer
. 2024 May;
205:114104.
PMID: 38733716
Background: The epidemiology of colorectal cancer (CRC) has changed rapidly over the years. The aim of this study was to assess the trends in incidence, treatment, and relative survival (RS)...
8.
van der Ven R, van den Heuvel T, Rovers K, Nienhuijs S, van Erning F, de Hingh I
Ann Surg Oncol
. 2024 Mar;
31(6):3787-3788.
PMID: 38498087
No abstract available.
9.
van der Ven R, van den Heuvel T, Rovers K, Nienhuijs S, Boerma D, van Grevenstein W, et al.
Ann Surg Oncol
. 2024 Mar;
31(6):3758-3768.
PMID: 38453767
Background: Before 2016, patients with isolated synchronous colorectal peritoneal metastases (PMCRC) diagnosed in expert centers had a higher odds of undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) and better...
10.
de Back T, Linssen J, van Erning F, Verbakel C, Schafrat P, Vermeulen L, et al.
Eur J Cancer
. 2024 Jan;
199:113529.
PMID: 38232410
Background: Small intestinal adenocarcinomas (SIAs) are rare. Hence, randomized controlled trials are lacking and understanding of the disease features is limited. This nationwide cohort investigates incidence, treatment and prognosis of...